{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T09:57:44Z","timestamp":1794391064688,"version":"4.9.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572962"],"award-info":[{"award-number":["82572962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65762-4","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T15:27:37Z","timestamp":1764343657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["IFN-\u03b3-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Shiqun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3674-256X","authenticated-orcid":false,"given":"Xin","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7887-8719","authenticated-orcid":false,"given":"Xiaoqing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7384-2490","authenticated-orcid":false,"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8559-616X","authenticated-orcid":false,"given":"Jiang-Jiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"65762_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"65762_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cytogfr.2018.01.007","volume":"39","author":"S Farajzadeh Valilou","year":"2018","unstructured":"Farajzadeh Valilou, S., Keshavarz-Fathi, M., Silvestris, N., Argentiero, A. & Rezaei, N. The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer. Cytokine Growth Factor Rev. 39, 46\u201361 (2018).","journal-title":"Cytokine Growth Factor Rev."},{"key":"65762_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell 38, 167\u2013197 (2020).","journal-title":"Cancer Cell"},{"key":"65762_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/08830180902978120","volume":"28","author":"F Zhou","year":"2009","unstructured":"Zhou, F. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int. Rev. Immunol. 28, 239\u2013260 (2009).","journal-title":"Int. Rev. Immunol."},{"key":"65762_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35948-9","volume":"14","author":"JM Mazet","year":"2023","unstructured":"Mazet, J. M. et al. IFN\u03b3 signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells. Nat. Commun. 14, 321 (2023).","journal-title":"Nat. Commun."},{"key":"65762_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00228-x","volume":"8","author":"D Jorgovanovic","year":"2020","unstructured":"Jorgovanovic, D., Song, M., Wang, L. & Zhang, Y. Roles of IFN-\u03b3 in tumor progression and regression: a review. Biomark. Res. 8, 49 (2020).","journal-title":"Biomark. Res."},{"key":"65762_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","volume":"81","author":"D Komander","year":"2012","unstructured":"Komander, D. & Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203\u2013229 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"65762_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41580-022-00543-1","volume":"24","author":"I Dikic","year":"2023","unstructured":"Dikic, I. & Schulman, B. A. An expanded lexicon for the ubiquitin code. Nat. Rev. Mol. Cell Biol. 24, 273\u2013287 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"65762_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.coi.2012.10.008","volume":"25","author":"JM Moffat","year":"2013","unstructured":"Moffat, J. M., Mintern, J. D. & Villadangos, J. A. Control of MHC II antigen presentation by ubiquitination. Curr. Opin. Immunol. 25, 109\u2013114 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"65762_CR10","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1053\/j.gastro.2021.12.273","volume":"162","author":"AN Hosein","year":"2022","unstructured":"Hosein, A. N. et al. Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma. Gastroenterology 162, 1303\u20131318 e1318 (2022).","journal-title":"Gastroenterology"},{"key":"65762_CR11","doi-asserted-by":"publisher","first-page":"100548","DOI":"10.1016\/j.mcpro.2023.100548","volume":"22","author":"Z Yal\u00e7in","year":"2023","unstructured":"Yal\u00e7in, Z. et al. Ubiquitinome profiling reveals in vivo UBE2D3 targets and implicates UBE2D3 in protein quality control. Mol. Cell Proteom. 22, 100548 (2023).","journal-title":"Mol. Cell Proteom."},{"key":"65762_CR12","doi-asserted-by":"publisher","first-page":"674286","DOI":"10.3389\/fonc.2021.674286","volume":"11","author":"Z Pan","year":"2021","unstructured":"Pan, Z., Bao, J., Zhang, L. & Wei, S. UBE2D3 activates SHP-2 ubiquitination to promote glycolysis and proliferation of glioma via regulating STAT3 signaling pathway. Front. Oncol. 11, 674286 (2021).","journal-title":"Front. Oncol."},{"key":"65762_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01538-4","volume":"21","author":"S Qi","year":"2022","unstructured":"Qi, S. et al. Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis. Mol. Cancer 21, 70 (2022).","journal-title":"Mol. Cancer"},{"key":"65762_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.molcel.2022.11.021","volume":"83","author":"C Jiang","year":"2023","unstructured":"Jiang, C. et al. Ring domains are essential for GATOR2-dependent mTORC1 activation. Mol. Cell 83, 74\u201389.e79 (2023).","journal-title":"Mol. Cell"},{"key":"65762_CR15","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1053\/j.gastro.2023.02.025","volume":"164","author":"X Jiang","year":"2023","unstructured":"Jiang, X. et al. Targeting UBE2T potentiates gemcitabine efficacy in pancreatic cancer by regulating pyrimidine metabolism and replication stress. Gastroenterology 164, 1232\u20131247 (2023).","journal-title":"Gastroenterology"},{"key":"65762_CR16","doi-asserted-by":"publisher","first-page":"eabb7695","DOI":"10.1126\/scitranslmed.abb7695","volume":"14","author":"L Barreyro","year":"2022","unstructured":"Barreyro, L. et al. Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia. Sci. Transl. Med. 14, eabb7695 (2022).","journal-title":"Sci. Transl. Med."},{"key":"65762_CR17","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.molcel.2024.01.024","volume":"84","author":"C He","year":"2024","unstructured":"He, C. et al. UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity. Mol. Cell 84, 1120\u20131138.e1128 (2024).","journal-title":"Mol. Cell"},{"key":"65762_CR18","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1016\/j.cell.2023.07.016","volume":"186","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. A membrane-associated MHC-I inhibitory axis for cancer immune evasion. Cell 186, 3903\u20133920.e3921 (2023).","journal-title":"Cell"},{"key":"65762_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek, K. N. & Komander, D. Ubiquitin modifications. Cell Res. 26, 399\u2013422 (2016).","journal-title":"Cell Res."},{"key":"65762_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nsmb.2780","volume":"21","author":"CE Berndsen","year":"2014","unstructured":"Berndsen, C. E. & Wolberger, C. New insights into ubiquitin E3 ligase mechanism. Nat. Struct. Mol. Biol. 21, 301\u2013307 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"65762_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrm2780","volume":"10","author":"Y Ye","year":"2009","unstructured":"Ye, Y. & Rape, M. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 10, 755\u2013764 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"65762_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-019-0079-0","volume":"3","author":"H Takeshima","year":"2019","unstructured":"Takeshima, H. & Ushijima, T. Accumulation of genetic and epigenetic alterations in normal cells and cancer risk. NPJ Precis. Oncol. 3, 7 (2019).","journal-title":"NPJ Precis. Oncol."},{"key":"65762_CR23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.devcel.2024.03.018","volume":"59","author":"Y Chang","year":"2024","unstructured":"Chang, Y. et al. The UBE2F-CRL5(ASB11)-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells. Dev. Cell 59, 1317\u20131332.e1315 (2024).","journal-title":"Dev. Cell"},{"key":"65762_CR24","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/0008-5472.CAN-20-0790","volume":"81","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. MDMX recruits UbcH5c to facilitate MDM2 E3 ligase activity and subsequent p53 degradation in vivo. Cancer Res. 81, 898\u2013909 (2021).","journal-title":"Cancer Res."},{"key":"65762_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jcmgh.2021.08.003","volume":"13","author":"P Ray","year":"2022","unstructured":"Ray, P. et al. UBCH5 family members differentially impact stabilization of mutant p53 via RNF128 Iso1 during Barrett\u2019s progression to esophageal adenocarcinoma. Cell Mol. Gastroenterol. Hepatol. 13, 129\u2013149 (2022).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"65762_CR26","doi-asserted-by":"publisher","first-page":"42169","DOI":"10.1074\/jbc.M403362200","volume":"279","author":"MK Saville","year":"2004","unstructured":"Saville, M. K. et al. Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B\/C in vivo. J. Biol. Chem. 279, 42169\u201342181 (2004).","journal-title":"J. Biol. Chem."},{"key":"65762_CR27","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1053\/j.gastro.2013.07.049","volume":"145","author":"SJ Murphy","year":"2013","unstructured":"Murphy, S. J. et al. Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor. Gastroenterology 145, 1098\u20131109.e1091 (2013).","journal-title":"Gastroenterology"},{"key":"65762_CR28","doi-asserted-by":"crossref","unstructured":"Sullivan, M. R. et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. Elife 8, e44235 (2019).","DOI":"10.7554\/eLife.44235"},{"key":"65762_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15138","volume":"8","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity. Nat. Commun. 8, 15138 (2017).","journal-title":"Nat. Commun."},{"key":"65762_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn, J. R. & Wilson, C. B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 96, 41\u2013101 (2007).","journal-title":"Adv. Immunol."},{"key":"65762_CR31","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/s41586-025-08732-6","volume":"640","author":"S Yuan","year":"2025","unstructured":"Yuan, S. et al. VDAC2 loss elicits tumour destruction and inflammation for cancer therapy. Nature 640, 1062\u20131071 (2025).","journal-title":"Nature"},{"key":"65762_CR32","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1002\/mco2.124","volume":"3","author":"HQ Wang","year":"2022","unstructured":"Wang, H. Q. et al. STAT3 pathway in cancers: past, present, and future. MedComm 3, e124 (2022).","journal-title":"MedComm"},{"key":"65762_CR33","doi-asserted-by":"publisher","first-page":"12245","DOI":"10.1074\/jbc.M110.191031","volume":"286","author":"Y Wu","year":"2011","unstructured":"Wu, Y. et al. Up-regulation and sustained activation of Stat1 are essential for interferon-gamma (IFN-gamma)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expression in human pancreatic cancer cell lines. J. Biol. Chem. 286, 12245\u201312256 (2011).","journal-title":"J. Biol. Chem."},{"key":"65762_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ccell.2020.05.010","volume":"38","author":"LF Escobar-Hoyos","year":"2020","unstructured":"Escobar-Hoyos, L. F. et al. Altered RNA splicing by mutant p53 activates oncogenic RAS signaling in pancreatic cancer. Cancer Cell 38, 198\u2013211.e198 (2020).","journal-title":"Cancer Cell"},{"key":"65762_CR35","doi-asserted-by":"publisher","first-page":"114202","DOI":"10.1016\/j.celrep.2024.114202","volume":"43","author":"H Shrestha","year":"2024","unstructured":"Shrestha, H. et al. The Janus kinase 1 is critical for pancreatic cancer initiation and progression. Cell Rep. 43, 114202 (2024).","journal-title":"Cell Rep."},{"key":"65762_CR36","doi-asserted-by":"publisher","first-page":"1265818","DOI":"10.3389\/fimmu.2023.1265818","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies. Front. Immunol. 14, 1265818 (2023).","journal-title":"Front. Immunol."},{"key":"65762_CR37","first-page":"717","volume":"44","author":"TH Corbett","year":"1984","unstructured":"Corbett, T. H. et al. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL\/6 mice. Cancer Res. 44, 717\u2013726 (1984).","journal-title":"Cancer Res."},{"key":"65762_CR38","first-page":"259","volume":"2","author":"Z Fan","year":"2005","unstructured":"Fan, Z. & Zhang, Q. Molecular mechanisms of lymphocyte-mediated cytotoxicity. Cell Mol. Immunol. 2, 259\u2013264 (2005).","journal-title":"Cell Mol. Immunol."},{"key":"65762_CR39","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman, I., Chen, D. S., Powles, T. & Turley, S. J. The cancer-immunity cycle: Indication, genotype, and immunotype. Immunity 56, 2188\u20132205 (2023).","journal-title":"Immunity"},{"key":"65762_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/BF00216802","volume":"37","author":"SH Powis","year":"1993","unstructured":"Powis, S. H. et al. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics 37, 373\u2013380 (1993).","journal-title":"Immunogenetics"},{"key":"65762_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46279-5","volume":"9","author":"MER Maitland","year":"2019","unstructured":"Maitland, M. E. R. et al. The mammalian CTLH complex is an E3 ubiquitin ligase that targets its subunit muskelin for degradation. Sci. Rep. 9, 9864 (2019).","journal-title":"Sci. Rep."},{"key":"65762_CR42","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41423-023-01065-2","volume":"20","author":"F Liu","year":"2023","unstructured":"Liu, F. et al. MAVS-loaded unanchored Lys63-linked polyubiquitin chains activate the RIG-I-MAVS signaling cascade. Cell Mol. Immunol. 20, 1186\u20131202 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"65762_CR43","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1021\/acs.jmedchem.6b01829","volume":"60","author":"H Chen","year":"2017","unstructured":"Chen, H. et al. Discovery of potent small-molecule inhibitors of ubiquitin-conjugating enzyme UbcH5c from \u03b1-santonin derivatives. J. Med. Chem. 60, 6828\u20136852 (2017).","journal-title":"J. Med. Chem."},{"key":"65762_CR44","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.trecan.2018.04.001","volume":"4","author":"AH Morrison","year":"2018","unstructured":"Morrison, A. H., Byrne, K. T. & Vonderheide, R. H. Immunotherapy and prevention of pancreatic cancer. Trends Cancer 4, 418\u2013428 (2018).","journal-title":"Trends Cancer"},{"key":"65762_CR45","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa2119662","volume":"386","author":"R Leidner","year":"2022","unstructured":"Leidner, R. et al. Neoantigen T-cell receptor gene therapy in pancreatic cancer. N. Engl. J. Med. 386, 2112\u20132119 (2022).","journal-title":"N. Engl. J. Med."},{"key":"65762_CR46","doi-asserted-by":"crossref","unstructured":"Poole, A. et al. Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen. Nat. Commun. 13, 5333 (2022).","DOI":"10.1038\/s41467-022-32811-1"},{"key":"65762_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42010-1","volume":"14","author":"D Lu","year":"2023","unstructured":"Lu, D. et al. KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors. Nat. Commun. 14, 6389 (2023).","journal-title":"Nat. Commun."},{"key":"65762_CR48","doi-asserted-by":"publisher","first-page":"12826","DOI":"10.1073\/pnas.1921964117","volume":"117","author":"MJW Sim","year":"2020","unstructured":"Sim, M. J. W. et al. High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D. Proc. Natl. Acad. Sci. 117, 12826\u201312835 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"65762_CR49","doi-asserted-by":"crossref","unstructured":"Lentsch, E. et al. CRISPR\/Cas9-mediated knock-out of Kras(G12D) mutated pancreatic cancer cell lines. Int. J. Mol. Sci. 20, 5706 (2019).","DOI":"10.3390\/ijms20225706"},{"key":"65762_CR50","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/neuonc\/noad256","volume":"26","author":"J Obacz","year":"2024","unstructured":"Obacz, J. et al. IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma. Neuro Oncol. 26, 858\u2013871 (2024).","journal-title":"Neuro Oncol."},{"key":"65762_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten, F. R. & Grivennikov, S. I. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51, 27\u201341 (2019).","journal-title":"Immunity"},{"key":"65762_CR52","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","volume":"20","author":"A Del Prete","year":"2023","unstructured":"Del Prete, A. et al. Dendritic cell subsets in cancer immunity and tumor antigen sensing. Cell Mol. Immunol. 20, 432\u2013447 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"65762_CR53","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"65762_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31579-8","volume":"13","author":"T Imamura","year":"2023","unstructured":"Imamura, T. et al. Characterization of pancreatic cancer with ultra-low tumor mutational burden. Sci. Rep. 13, 4359 (2023).","journal-title":"Sci. Rep."},{"key":"65762_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-015-0134-4","volume":"8","author":"V Folgiero","year":"2015","unstructured":"Folgiero, V. et al. TIM-3\/Gal-9 interaction induces IFN\u03b3-dependent IDO1 expression in acute myeloid leukemia blast cells. J. Hematol. Oncol. 8, 36 (2015).","journal-title":"J. Hematol. Oncol."},{"key":"65762_CR56","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/j.gastro.2019.10.025","volume":"158","author":"J Xiang","year":"2020","unstructured":"Xiang, J. et al. Disruption of SIRT7 increases the efficacy of checkpoint inhibitor via MEF2D regulation of programmed cell death 1 ligand 1 in hepatocellular carcinoma cells. Gastroenterology 158, 664\u2013678.e624 (2020).","journal-title":"Gastroenterology"},{"key":"65762_CR57","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1158\/2159-8290.CD-21-0694","volume":"12","author":"F Wiede","year":"2022","unstructured":"Wiede, F. et al. PTP1B is an intracellular checkpoint that limits T-cell and CAR T-cell antitumor immunity. Cancer Discov. 12, 752\u2013773 (2022).","journal-title":"Cancer Discov."},{"key":"65762_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35710-7","volume":"14","author":"W Lin","year":"2023","unstructured":"Lin, W. et al. Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation. Nat. Commun. 14, 265 (2023).","journal-title":"Nat. Commun."},{"key":"65762_CR59","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto, K. et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature 581, 100\u2013105 (2020).","journal-title":"Nature"},{"key":"65762_CR60","doi-asserted-by":"crossref","unstructured":"Stifter, K. et al. IFN-\u03b3 treatment protocol for MHC-I(lo)\/PD-L1(+) pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential. J. Immunother. Cancer 8, e000692 (2020).","DOI":"10.1136\/jitc-2020-000692"},{"key":"65762_CR61","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature10822","volume":"482","author":"L Jin","year":"2012","unstructured":"Jin, L. et al. Ubiquitin-dependent regulation of COPII coat size and function. Nature 482, 495\u2013500 (2012).","journal-title":"Nature"},{"key":"65762_CR62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1042\/BJ20121903","volume":"451","author":"A Ohta","year":"2013","unstructured":"Ohta, A. et al. The CUL3-KLHL3 E3 ligase complex mutated in Gordon\u2019s hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction. Biochem J. 451, 111\u2013122 (2013).","journal-title":"Biochem J."},{"key":"65762_CR63","doi-asserted-by":"publisher","first-page":"1058751","DOI":"10.3389\/fcell.2022.1058751","volume":"10","author":"M Roman-Trufero","year":"2022","unstructured":"Roman-Trufero, M. & Dillon, N. The UBE2D ubiquitin conjugating enzymes: Potential regulatory hubs in development, disease and evolution. Front. Cell Dev. Biol. 10, 1058751 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"65762_CR64","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/ncb3260","volume":"17","author":"CK Schmidt","year":"2015","unstructured":"Schmidt, C. K. et al. Systematic E2 screening reveals a UBE2D-RNF138-CtIP axis promoting DNA repair. Nat. Cell Biol. 17, 1458\u20131470 (2015).","journal-title":"Nat. Cell Biol."},{"key":"65762_CR65","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/jnci\/djt184","volume":"105","author":"P Leone","year":"2013","unstructured":"Leone, P. et al. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. J. Natl. Cancer Inst. 105, 1172\u20131187 (2013).","journal-title":"J. Natl. Cancer Inst."},{"key":"65762_CR66","first-page":"8647","volume":"61","author":"B Seliger","year":"2001","unstructured":"Seliger, B. et al. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. Cancer Res. 61, 8647\u20138650 (2001).","journal-title":"Cancer Res."},{"key":"65762_CR67","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.1158\/0008-5472.CAN-05-0044","volume":"65","author":"M Kloor","year":"2005","unstructured":"Kloor, M. et al. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Res. 65, 6418\u20136424 (2005).","journal-title":"Cancer Res."},{"key":"65762_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature07657","volume":"458","author":"D Zehn","year":"2009","unstructured":"Zehn, D., Lee, S. Y. & Bevan, M. J. Complete but curtailed T-cell response to very low-affinity antigen. Nature 458, 211\u2013214 (2009).","journal-title":"Nature"},{"key":"65762_CR69","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1038\/s41375-022-01585-2","volume":"36","author":"ML Olson","year":"2022","unstructured":"Olson, M. L. et al. Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion. Leukemia 36, 1943\u20131946 (2022).","journal-title":"Leukemia"},{"key":"65762_CR70","doi-asserted-by":"publisher","first-page":"e2202914","DOI":"10.1002\/advs.202202914","volume":"9","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. Pyroptosis remodeling tumor microenvironment to enhance pancreatic cancer immunotherapy driven by membrane anchoring photosensitizer. Adv. Sci. 9, e2202914 (2022).","journal-title":"Adv. Sci."},{"key":"65762_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39683-z","volume":"14","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma. Nat. Commun. 14, 4367 (2023).","journal-title":"Nat. Commun."},{"key":"65762_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2007.11.019","volume":"28","author":"KB Lin","year":"2008","unstructured":"Lin, K. B. et al. The rap GTPases regulate B cell morphology, immune-synapse formation, and signaling by particulate B cell receptor ligands. Immunity 28, 75\u201387 (2008).","journal-title":"Immunity"},{"key":"65762_CR73","doi-asserted-by":"crossref","unstructured":"Zuccarino-Catania, G. & Shlomchik, M. Adoptive transfer of memory B cells. Bio Protoc. 5, e1563 (2015).","DOI":"10.21769\/BioProtoc.1563"},{"key":"65762_CR74","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s00262-021-03101-4","volume":"71","author":"A Page","year":"2022","unstructured":"Page, A. et al. Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies. Cancer Immunol. Immunother. 71, 1771\u20131775 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"65762_CR75","doi-asserted-by":"publisher","first-page":"e19217","DOI":"10.1371\/journal.pone.0019217","volume":"6","author":"H Haslene-Hox","year":"2011","unstructured":"Haslene-Hox, H. et al. A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue. PloS ONE 6, e19217 (2011).","journal-title":"PloS ONE"},{"key":"65762_CR76","doi-asserted-by":"crossref","unstructured":"Chen, X. et al. An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy. Nat. Cancer 5, 1063\u20131081 (2024).","DOI":"10.1038\/s43018-024-00760-x"},{"key":"65762_CR77","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s43018-022-00448-0","volume":"3","author":"L Tian","year":"2022","unstructured":"Tian, L. et al. Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity. Nat. Cancer 3, 1318\u20131335 (2022).","journal-title":"Nat. Cancer"},{"key":"65762_CR78","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s43018-023-00575-2","volume":"4","author":"Y Adachi","year":"2023","unstructured":"Adachi, Y. et al. Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS. Nat. Cancer 4, 829\u2013843 (2023).","journal-title":"Nat. Cancer"},{"key":"65762_CR79","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","volume":"83","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Mol. Cell 83, 4352\u20134369.e4358 (2023).","journal-title":"Mol. Cell"},{"key":"65762_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molimm.2018.05.025","volume":"101","author":"P Praest","year":"2018","unstructured":"Praest, P. et al. The influence of TAP1 and TAP2 gene polymorphisms on TAP function and its inhibition by viral immune evasion proteins. Mol. Immunol. 101, 55\u201364 (2018).","journal-title":"Mol. Immunol."},{"key":"65762_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7199","volume":"6","author":"H Fischbach","year":"2015","unstructured":"Fischbach, H. et al. Ultrasensitive quantification of TAP-dependent antigen compartmentalization in scarce primary immune cell subsets. Nat. Commun. 6, 6199 (2015).","journal-title":"Nat. Commun."},{"key":"65762_CR82","doi-asserted-by":"publisher","first-page":"216366","DOI":"10.1016\/j.canlet.2023.216366","volume":"573","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Engineered TCR T-cell therapy targeting mass spectrometry-identified natural epitope in PDAC. Cancer Lett. 573, 216366 (2023).","journal-title":"Cancer Lett."},{"key":"65762_CR83","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. iProX: an integrated proteome resource. Nucleic Acids Res. 47, D1211\u2013D1217 (2019).","journal-title":"Nucleic Acids Res."},{"key":"65762_CR84","doi-asserted-by":"publisher","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","volume":"50","author":"T Chen","year":"2022","unstructured":"Chen, T. et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 50, D1522\u2013D1527 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65762-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65762-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65762-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:31:44Z","timestamp":1764739904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65762-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65762"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65762-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10733"}}